BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18076633)

  • 1. Overexpression of program death-1 in T cells has mild impact on allograft survival.
    Chen L; Hussien Y; Hwang KW; Wang Y; Zhou P; Alegre ML
    Transpl Int; 2008 Jan; 21(1):21-9. PubMed ID: 18076633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L; Han R; Hancock WW
    Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival.
    Dudler J; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
    Transplantation; 2006 Dec; 82(12):1733-7. PubMed ID: 17198268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft.
    Hüser N; Fasan A; Semmrich M; Schmidbauer P; Holzmann B; Laschinger M
    Int Immunol; 2010 Jan; 22(1):35-44. PubMed ID: 19946016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
    Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
    J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
    Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
    Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
    Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
    J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
    Wang S; Diao H; Guan Q; Jevnikar AM; Du C
    Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy.
    Funeshima-Fuji N; Fujino M; Xie L; Kimura H; Takahara S; Ezaki T; Zhu BT; Li XK
    J Heart Lung Transplant; 2009 Feb; 28(2):176-82. PubMed ID: 19201344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
    Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
    Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
    Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q
    Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
    Suzuki J; Koga N; Kosuge H; Ogawa M; Haraguchi G; Maejima Y; Saiki H; Isobe M
    Transplantation; 2007 Apr; 83(8):1093-7. PubMed ID: 17452900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.